Published October 4, 2018
| Version v1
Dataset
Open
Screening Compounds of Interest against USP5 Zf-UBD by SPR #2
- 1. University of Toronto, Structural Genomics Consortium
Description
Determination of binding affinities of compounds of interest previously identified in a 19F-NMR spectroscopy assay against USP5 zinc finger ubiquitin binding domain (Zf-UBD) with a surface plasmon resonance (SPR) assay
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
1_SPR2.pdf
Files
(116.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:cc29cd5c017be9c065d1beed19377dba
|
524.2 kB | Preview Download |
|
md5:54915b5a4b4da33350740656fb0363fd
|
29.1 MB | Download |
|
md5:aee9b278831988965b12549cd24a31c9
|
29.1 MB | Download |
|
md5:8733472a7371b22f45cdf081d202407f
|
29.1 MB | Download |
|
md5:fd2d7f605fddf3c22395833bd3138ac7
|
29.1 MB | Download |
|
md5:86eafd5696ddb0d3d802dbf38c67a63a
|
6.4 kB | Download |